Collins v. Feder

District Court, D. Connecticut·Decided December 10, 2024·No. 3:23-cv-00071·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

RICARDO COLLINS, : Plaintiff, : Case No. 3:23-cv-71 (KAD) : v. : : INGRID FEDER, et al., : Defendants. : December 10, 2024

MEMORANDUM OF DECISION RE: DEFENDANTS’ [55], [58] MOTIONS FOR SUMMARY JUDGMENT

Kari A. Dooley, United States District Judge

Plaintiff Ricardo Collins, a pro se litigant currently incarcerated at MacDougall-Walker Correctional Institution (“MacDougall”), filed this civil rights action pursuant to 42 U.S.C. § 1983, asserting claims for deliberate indifference to serious medical needs against three Defendants: Dr. Ingrid Feder, Dr. Brian Rader, and APRN Chena McPherson. Plaintiff’s Second Amended Complaint1 (“SAC”) asserts two claims, both of which are based on the same allegations, namely, that: (1) Defendants failed to inform Plaintiff of certain side effects associated with the pain medication Gabapentin; and (2) upon learning that Plaintiff was experiencing unpleasant side effects, Defendants only increased Plaintiff’s dosage of the drug and otherwise failed to treat him. See generally SAC, ECF No. 27. On August 6, 2024, Defendant McPherson filed a Motion for Summary Judgment (hereinafter, the “McPherson MSJ”) asserting that Plaintiff failed to exhaust his administrative

1 Upon initial review, United States District Judge Omar A. Williams dismissed all of the claims in Plaintiff’s initial Complaint and Amended Complaint, except for Plaintiff’s deliberate indifference claim against then-defendant Dr. Lupis. See ECF No. 11. In a subsequent Order striking Plaintiff’s attempt to file a second amended complaint, the Court informed Plaintiff that if he did not include the claim against Dr. Lupis in his second amended complaint, any such claim would be considered abandoned. See ECF No. 21 at 3. Plaintiff thereafter filed the SAC. See ECF No. 27. As the SAC does not include any claims against Dr. Lupis despite the Court’s instruction, the Court considers all claims against Dr. Lupis to have been abandoned. remedies as to any claim against her. See McPherson MSJ, ECF No. 55. Likewise, on August 16, 2024, Defendants Feder and Rader filed a Motion for Summary Judgment (hereinafter, the “Feder & Rader MSJ”) which raises the same exhaustion defense.2 See Feder & Rader MSJ, ECF No. 58. On September 9, 2024, Plaintiff filed his initial responses to Defendants’ motions for summary

judgment. See ECF Nos. 61, 62. On September 10, 2024 and September 23, 2024, Defendants each filed reply briefs. See ECF Nos. 63, 64. With the Court’s permission, see ECF No. 67, on October 3, 2024 and October 9, 2024, Plaintiff filed supplemental responses to Defendants’ motions for summary judgment. See ECF Nos. 68, 71. On October 4, 2024 and October 23, 2024, Defendants each filed replies to Plaintiff’s supplemental responses. See ECF Nos. 69, 73. For the reasons set forth herein, Defendants’ motions for summary judgment are GRANTED. Facts3 Plaintiff alleges that on December 28, 2020, prior to undergoing a “tendon transfer,” Defendant Feder prescribed Gabapentin for Plaintiff’s pain management. See SAC at p. 1. The

SAC further asserts that Defendant Feder did not explain any side effects of the medication to Plaintiff to enable him to make an informed choice to take the medication, and he did not sign any documentation acknowledging that he was at risk of suffering any side effects. Id. Plaintiff contends that the Gabapentin did not relieve his pain, and in response to his continued complaints

2 On June 3, 2024, the Court granted Defendants’ motion to bifurcate the summary judgment phase and brief the threshold exhaustion issue first. See ECF No. 48. Accordingly, Defendants have not addressed in their motions— and indeed, the Court does not consider herein—the substantive merits of Plaintiff’s claims. 3 Notwithstanding the threshold exhaustion issue, the Court has included the facts alleged in the SAC as relevant background. The facts relating to Plaintiff’s exhaustion of his administrative remedies are taken from the parties’ Local Rule 56(a) Statements and supporting exhibits. Although many of these facts—and the exhibits which support them—are included in each of the Defendants’ separate Local Rule 56(a) Statements, for ease of reference the Court cites only to the Feder & Rader Rule 56 Statement for those overlapping statements and exhibits.

2 of pain, Plaintiff’s dosage was only increased. Id. While taking Gabapentin, Plaintiff suffered memory loss and heightened anxiety, conditions that he had never experienced before taking Gabapentin. Id. at pp. 1–2. The side-effects and pain worsened when Plaintiff was taken off Gabapentin. Id. at p. 2. Plaintiff claims that while he was taking Gabapentin, he informed each

Defendant at different times that the drug was ineffective, that he continued to be in pain, and that he was experiencing vision problems, memory loss, and heightened anxiety. Id. Nevertheless, Plaintiff alleges that none of the Defendants took any action in response to these complaints. Id. Exhaustion of Administrative Remedies Plaintiff has been continuously incarcerated within the Connecticut Department of Correction (“DOC”) from January 2003 through the present. See Defendants Feder & Rader’s Local Rule 56(a)1 Statement (“Feder & Rader Rule 56 Statement”), ECF No. 59, at ¶ 2; Plaintiff Rule 56(a)2 Statement (“Pl. Rule 56 Statement”), ECF No. 71, at ¶ 2. Plaintiff was incarcerated at Corrigan Correctional Center (“Corrigan”) from December 1, 2017 through September 3, 2021, with the exception of three days in March 2018, when he was taken to UConn Hospital. Feder &

Rader Rule 56 Statement at ¶ 3. Plaintiff was transferred to MacDougall on September 3, 2021, and is still at that facility. Id. at ¶¶ 4–5. As relevant here, Defendants Feder, Rader, and McPherson worked only at Corrigan, and all of Plaintiff’s encounters with Defendants occurred at Corrigan. Id. at ¶¶ 6–7. Plaintiff submitted two Health Services Reviews or Health Services Administrative Remedies (each referred to as “HSRs”) relating to the claims in this action, both of which were filed while he was incarcerated at MacDougall in June 2022 and July 2022, respectively. Id. at ¶¶ 9–11. Plaintiff did not file any HSR while confined at Corrigan. Id. at ¶ 10.

3 In his first HSR, filed on June 15, 2022, Plaintiff stated the problem as follows: I wrote Dr. Lupis on 6/7/22 about medication I had been getting. I explain to the Dr. Lupis that I had a surgery on my left foot and the UConn Doctor prescribe narontine for me. Dr. Lupis gave me Gabapentin instead of the narontie that was prescribe to be by the UConn Doctor because of this I’ve been experiencing short term memory loss, confusion forgetting the names of everyday objects and trouble sleeping. I also have anxiety issue. I would like to see a neurologist and find out why I’m having these memory losses. And I would like to get the narontie that prescribe to me by the UConn Doctors Please thank you (sic).

See Feder & Rader MSJ, Ex. H, at p. 2. On July 12, 2022, the first HSR was rejected because Plaintiff did not fully complete the form. Id. at p. 3. In his second HSR, filed on July 16, 2022, Plaintiff stated his claim as follows: I wrote Dr. Lupis on 6/7/22 about medication I had been getting. I explain to the Dr. Lupis that I had a surgery on my left foot and the UConn Doctor prescribe oxycodone, and Tylenol for me. Dr. Lupis gave me gabapentin instead of Oxycodone and Tylenol that was prescribe to me by the UConn Doctor. Because of that medication Dr. Lupis order for me I’ve been experiencing short term memory loss, confusion forgetting the names of everyday objects and trouble sleeping. I also have anxiety issue.

Free access — add to your briefcase to read the full text and ask questions with AI

Collins v. Feder, (D. Conn. 2024).

Collins v. Feder (Collins v. Feder) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Giordano v. MARKET AMERICA, INC.
599 F.3d 87 (Second Circuit, 2010)
Day v. Chaplin
354 F. App'x 472 (Second Circuit, 2009)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Porter v. Nussle
534 U.S. 516 (Supreme Court, 2002)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Brown v. Eli Lilly and Co.
654 F.3d 347 (Second Circuit, 2011)
Shelley Weinstock v. Columbia University
224 F.3d 33 (Second Circuit, 2000)
Christopher Graham v. Long Island Rail Road
230 F.3d 34 (Second Circuit, 2000)
Neal v. Goord
267 F.3d 116 (Second Circuit, 2001)
MacIas v. Zenk
495 F.3d 37 (Second Circuit, 2007)
Fisk v. Letterman
501 F. Supp. 2d 505 (S.D. New York, 2007)
Amador v. Andrews
655 F.3d 89 (Second Circuit, 2011)
Crawford v. Franklin Credit Management Corp.
758 F.3d 473 (Second Circuit, 2014)
Ross v. Blake
578 U.S. 632 (Supreme Court, 2016)
Kee v. City of New York
12 F.4th 150 (Second Circuit, 2021)
Robinson v. Concentra Health Services, Inc.
781 F.3d 42 (Second Circuit, 2015)